NucleoBio Corp
PrivateLast Round
Accelerator
Jun 1, 2017
Total Funding Raised
$25,000
Company Overview
NucleoBio Corp is a biotechnology company that develops RNA-based assays and molecular diagnostics for precision oncology derived from peer-reviewed research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NucleoBio Corp Comparables
Compare NucleoBio Corp with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MiRNA Scientific | 87% | |
| Minomic International | 85% | |
| LynxDx | 85% | |
NucleoBio Corp Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 1, 2017 |
Key People
Founding team and executive leadership
NucleoBio Corp Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Science Foundation | Grant |
NucleoBio Corp Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NucleoBio Corp's valuation, stock price, and market status.